cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis

Mark J Vignola1, David F Kashatus, Gregory A Taylor

  • 1Departments of Molecular Genetics and Microbiology, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina 27710, USA.

Insights

Chlamydia trachomatis infection activates RAS signaling pathways non-canonically. While ERK and phospholipase cPLA(2) inhibition doesn't affect human cells, it protects murine cells by boosting immunity-related GTPases (IRGs).

Area of Science:

  • Cellular microbiology
  • Immunology
  • Molecular signaling

Background:

  • Chlamydia trachomatis is an obligate intracellular bacterial pathogen.
  • Infection triggers sustained activation of RAS GTPase and downstream signaling, including ERK and cPLA(2), crucial for inflammation.
  • The precise role of RAS-mediated signaling in chlamydial replication and host immunity remains unclear.

Purpose of the Study:

  • To investigate if ERK and cPLA(2) activation during Chlamydia infection results from RAS signaling.
  • To determine the contribution of ERK and cPLA(2) to chlamydial replication and survival.
  • To elucidate the mechanisms underlying host cell defense against Chlamydia.

Main Methods:

  • Genetic and pharmacological inhibition of RAS, ERK, and cPLA(2) signaling pathways.
  • Comparative analysis of Chlamydia trachomatis replication and survival in human and murine cell lines.
  • Assessment of beta interferon and immunity-related GTPases (IRG) expression in infected cells.
  • Investigation of the role of MAPK p38 in cPLA(2) activation and IRG expression.

Main Results:

  • RAS, ERK, and cPLA(2) activation during Chlamydia infection are uncoupled, indicating non-canonical signaling.
  • Inhibition of ERK or cPLA(2) did not impede C. trachomatis replication in human cells.
  • Inhibition of ERK and cPLA(2) significantly protected murine cells against C. trachomatis, linked to impaired beta interferon and IRG expression in cPLA(2)-deficient cells.
  • MAPK p38 was identified as the primary activator of cPLA(2) and IRG expression in infected cells.

Conclusions:

  • Chlamydia trachomatis engages in non-canonical signaling pathways, uncoupling RAS, ERK, and cPLA(2).
  • Phospholipase cPLA(2) plays a critical role in inducing cell-autonomous immunity against Chlamydia in murine cells via beta interferon and IRG induction.
  • MAPK p38 is central to activating cPLA(2) and IRG-mediated immunity, highlighting a novel defense mechanism against intracellular pathogens.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...